| Literature DB >> 22218750 |
Henk van Steenbergen1, Linda Booij, Guido P H Band, Bernhard Hommel, A J Willem van der Does.
Abstract
Negative affect in healthy populations regulates the appraisal of demanding situations, which tunes subsequent effort mobilization and adjustments in cognitive control. In the present study, we hypothesized that dysphoria in depressed individuals similarly modulates this adaptation, possibly through a neural mechanism involving serotonergic regulation. We tested the effect of dysphoria induced by acute tryptophan depletion (ATD) in remitted depressed patients on conflict adaptation in a Simon task. ATD temporarily lowers the availability of the serotonin precursor L-Tryptophan and is known to increase depressive symptoms in approximately half of remitted depressed participants. We found that depressive symptoms induced by ATD were associated with increased conflict adaptation. Our finding extends recent observations implying an important role of affect in regulating conflict-driven cognitive control.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22218750 PMCID: PMC3341521 DOI: 10.3758/s13415-011-0078-2
Source DB: PubMed Journal: Cogn Affect Behav Neurosci ISSN: 1530-7026 Impact factor: 3.282
Fig. 1a Conflict adaptation in the Simon task as evidenced by a reduced compatibility effect after conflict trials versus nonconflict trials. Graphs shows mean reaction times (in milliseconds) and standard errors. b More depressive symptoms (MADRS score) after the high-dose ATD intervention are associated with increased conflict adaptation
Behavioral data for all sessions and conditions
| Reaction time (in milliseconds) | Error rate (in percentages) | |||
|---|---|---|---|---|
| M | SE | M | SE | |
| Baseline | ||||
| Compatible trial following a compatible trial | 655 | 14.4 | 0.6 | 0.3 |
| Incompatible trial following a compatible trial | 705 | 12.3 | 3.6 | 1.2 |
| Compatible trial following an incompatible trial | 676 | 12.1 | 0.9 | 0.4 |
| Incompatible trial following an incompatible trial | 675 | 11.6 | 1.0 | 0.5 |
| Low-dose session | ||||
| Compatible trial following a compatible trial | 650 | 16.8 | 1.4 | 0.9 |
| Incompatible trial following a compatible trial | 706 | 18.2 | 2.9 | 1.0 |
| Compatible trial following an incompatible trial | 688 | 16.7 | 0.9 | 0.9 |
| Incompatible trial following an incompatible trial | 680 | 14.4 | 0.8 | 0.8 |
| High-dose session | ||||
| Compatible trial following a compatible trial | 649 | 18.3 | 1.4 | 0.8 |
| Incompatible trial following a compatible trial | 711 | 19.9 | 2.3 | 0.9 |
| Compatible trial following an incompatible trial | 667 | 17.3 | 0.9 | 0.5 |
| Incompatible trial following an incompatible trial | 678 | 16.4 | 1.1 | 0.8 |